MENU
+Compare
FEMY
Stock ticker: NASDAQ
AS OF
Sep 24, 04:59 PM (EDT)
Price
$0.35
Change
+$0.01 (+2.94%)
Capitalization
11.22M

FEMY Femasys Forecast, Technical & Fundamental Analysis

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas... Show more

FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for FEMY with price predictions
Sep 23, 2025

FEMY's RSI Indicator ascends from oversold territory

The RSI Oscillator for FEMY moved out of oversold territory on September 22, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In of the 28 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for FEMY just turned positive on September 10, 2025. Looking at past instances where FEMY's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FEMY advanced for three days, in of 158 cases, the price rose further within the following month. The odds of a continued upward trend are .

FEMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on FEMY as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FEMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FEMY entered a downward trend on September 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.440) is normal, around the industry mean (10.825). P/E Ratio (0.000) is within average values for comparable stocks, (56.185). FEMY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.750). FEMY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (4.523) is also within normal values, averaging (14.891).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. FEMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FEMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

FEMY is expected to report earnings to fall 20.81% to -12 cents per share on November 06

Femasys FEMY Stock Earnings Reports
Q3'25
Est.
$-0.13
Q2'25
Est.
$-0.16
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.04
Q3'24
Missed
by $0.04
The last earnings report on August 11 showed earnings per share of -15 cents, meeting the estimate of -15 cents. With 244.07K shares outstanding, the current market capitalization sits at 11.22M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
3950 Johns Creek Court
Phone
+1 770 500-3910
Employees
34
Web
https://www.femasys.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IFBD1.350.23
+20.09%
Infobird Co Ltd
SBFG20.540.26
+1.28%
SB Financial Group
VIRT35.020.15
+0.43%
Virtu Financial Inc
SBAC198.820.82
+0.41%
SBA Communications Corp
KALV13.02-0.08
-0.61%
KalVista Pharmaceuticals

FEMY and Stocks

Correlation & Price change

A.I.dvisor tells us that FEMY and LUCD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEMY and LUCD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
-4.70%
LUCD - FEMY
31%
Poorly correlated
-2.31%
OM - FEMY
30%
Poorly correlated
-5.83%
GH - FEMY
27%
Poorly correlated
-0.10%
TWST - FEMY
27%
Poorly correlated
-0.61%
ESTA - FEMY
26%
Poorly correlated
+2.36%
More

Groups containing FEMY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
-4.70%
Pharmaceuticals
category (388 stocks)
19%
Poorly correlated
-0.30%
Pharmaceuticals: Other
category (103 stocks)
17%
Poorly correlated
-0.53%